{"id":"https://openalex.org/W4248752180","doi":"https://doi.org/10.1097/iae.0000000000000548","title":"CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE: The TWIN Study","display_name":"CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE: The TWIN Study","alternate_titles":[],"publication_year":2015,"publication_date":"2015-04-22","ids":{"openalex":"https://openalex.org/W4248752180","doi":"https://doi.org/10.1097/iae.0000000000000548"},"language":"en","primary_location":{"id":"doi:10.1097/iae.0000000000000548","doi":"https://doi.org/10.1097/iae.0000000000000548","is_oa":false,"landing_page_url":"https://doi.org/10.1097/iae.0000000000000548","pdf_url":null,"source":{"id":"https://openalex.org/S19572933","display_name":"Retina","issn_l":"0275-004X","issn":["0275-004X","1539-2864"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retina","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4248752180"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086662698","display_name":"Eric H. Souied","orcid":"https://orcid.org/0000-0001-9388-202X","observed_orcids":["https://orcid.org/0000-0001-9388-202X"]},"institutions":[{"id":"https://openalex.org/I197681013","display_name":"Universit\u00e9 Paris-Est Cr\u00e9teil","ror":"https://ror.org/05ggc9x40","country_code":"FR","type":"education","lineage":["https://openalex.org/I197681013","https://openalex.org/I2800365227"]},{"id":"https://openalex.org/I4210109733","display_name":"Centre Ophtalmologique d'Imagerie et de Laser","ror":"https://ror.org/01ddmwy83","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210109733"]},{"id":"https://openalex.org/I4210159273","display_name":"H\u00f4pital Intercommunal de Cr\u00e9teil","ror":"https://ror.org/04n1nkp35","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210159273"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Eric H. Souied","raw_affiliation_strings":["*Department of Ophthalmology, H\u00f4pital Intercommunal de Cr\u00e9teil, University Paris Est Cr\u00e9teil, Cr\u00e9teil, France; \u2020Department of Ophthalmology, Centre Hospitalier, Orleans, France; \u2021Centre d'Imagerie de l'Ecole Militaire, Paris, France; \u00a7Centre Ophtalmologique d'Imagerie et de Laser, Paris France; and \u00b6Novartis Pharma SAS, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"*Department of Ophthalmology, H\u00f4pital Intercommunal de Cr\u00e9teil, University Paris Est Cr\u00e9teil, Cr\u00e9teil, France; \u2020Department of Ophthalmology, Centre Hospitalier, Orleans, France; \u2021Centre d'Imagerie de l'Ecole Militaire, Paris, France; \u00a7Centre Ophtalmologique d'Imagerie et de Laser, Paris France; and \u00b6Novartis Pharma SAS, Paris, France","institution_ids":["https://openalex.org/I197681013","https://openalex.org/I4210109733","https://openalex.org/I4210159273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046347482","display_name":"Hassiba Oubraham","orcid":"https://orcid.org/0000-0002-9004-6867","observed_orcids":["https://orcid.org/0000-0002-9004-6867"]},"institutions":[{"id":"https://openalex.org/I4210144652","display_name":"Centre hospitalier universitaire d'Orl\u00e9ans","ror":"https://ror.org/04yvax419","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210144652"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hassiba Oubraham","raw_affiliation_strings":["Department of Ophthalmology, Centre Hospitalier, Orleans, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Centre Hospitalier, Orleans, France;","institution_ids":["https://openalex.org/I4210144652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028081204","display_name":"G. Mimoun","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G\u00e9rard Mimoun","raw_affiliation_strings":["Centre d'Imagerie de l'Ecole Militaire, Paris, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre d'Imagerie de l'Ecole Militaire, Paris, France;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053183041","display_name":"Salomon Yves Cohen","orcid":"https://orcid.org/0000-0003-1181-4379","observed_orcids":["https://orcid.org/0000-0003-1181-4379"]},"institutions":[{"id":"https://openalex.org/I4210109733","display_name":"Centre Ophtalmologique d'Imagerie et de Laser","ror":"https://ror.org/01ddmwy83","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210109733"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Salomon Y. Cohen","raw_affiliation_strings":["Centre Ophtalmologique d'Imagerie et de Laser, Paris France; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Ophtalmologique d'Imagerie et de Laser, Paris France; and","institution_ids":["https://openalex.org/I4210109733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032157810","display_name":"St\u00e9phane Qu\u00e9r\u00e9","orcid":"https://orcid.org/0000-0001-8832-6053","observed_orcids":["https://orcid.org/0000-0001-8832-6053"]},"institutions":[{"id":"https://openalex.org/I4210092929","display_name":"Novartis (France)","ror":"https://ror.org/00geypp27","country_code":"FR","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210092929"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"St\u00e9phane Quere","raw_affiliation_strings":["Novartis Pharma SAS, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma SAS, Paris, France","institution_ids":["https://openalex.org/I4210092929"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079251201","display_name":"Audrey Derveloy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092929","display_name":"Novartis (France)","ror":"https://ror.org/00geypp27","country_code":"FR","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210092929"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Audrey Derveloy","raw_affiliation_strings":["Novartis Pharma SAS, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma SAS, Paris, France","institution_ids":["https://openalex.org/I4210092929"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5086662698"],"corresponding_institution_ids":["https://openalex.org/I197681013","https://openalex.org/I4210109733","https://openalex.org/I4210159273"],"apc_list":null,"apc_paid":null,"fwci":8.687,"has_fulltext":false,"cited_by_count":67,"citation_normalized_percentile":{"value":0.98444401,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"35","issue":"9","first_page":"1743","last_page":"1749"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neovascular-age-related-macular-degeneration","display_name":"neovascular age-related macular degeneration","score":0.9950000047683716},{"id":"https://openalex.org/keywords/intravitreal-ranibizumab","display_name":"intravitreal ranibizumab","score":0.9259999990463257},{"id":"https://openalex.org/keywords/visual-acuity-change","display_name":"visual acuity change","score":0.7419999837875366},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.5950000286102295},{"id":"https://openalex.org/keywords/induction-therapy","display_name":"induction therapy","score":0.6079999804496765},{"id":"https://openalex.org/keywords/retreatment","display_name":"retreatment","score":0.7609999775886536},{"id":"https://openalex.org/keywords/treatment-interval","display_name":"treatment interval","score":0.34599998593330383},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.7680000066757202},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.6000000238418579}],"concepts":[{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.9477592706680298},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9172057509422302},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.7667341232299805},{"id":"https://openalex.org/C2776403814","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Macular degeneration","level":2,"score":0.7367284893989563},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.6068768501281738},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5846199989318848},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.282492071390152},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.19245308637619019},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.07327771186828613}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/iae.0000000000000548","doi":"https://doi.org/10.1097/iae.0000000000000548","is_oa":false,"landing_page_url":"https://doi.org/10.1097/iae.0000000000000548","pdf_url":null,"source":{"id":"https://openalex.org/S19572933","display_name":"Retina","issn_l":"0275-004X","issn":["0275-004X","1539-2864"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retina","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1985359220","https://openalex.org/W1995067794","https://openalex.org/W1997244967","https://openalex.org/W2003324689","https://openalex.org/W2041033640","https://openalex.org/W2052102026","https://openalex.org/W2064660874","https://openalex.org/W2064939547","https://openalex.org/W2084812174","https://openalex.org/W2085712747","https://openalex.org/W2124415048"],"related_works":["https://openalex.org/W2623875535","https://openalex.org/W2144656873","https://openalex.org/W2799551240","https://openalex.org/W2006778824","https://openalex.org/W2281889375","https://openalex.org/W2341265428","https://openalex.org/W1761901501","https://openalex.org/W2730061686","https://openalex.org/W2023170521","https://openalex.org/W2029569706"],"abstract_inverted_index":{"In":[0,69],"Brief":[1],"Purpose:":[2],"The":[3,41],"real-life":[4],"LUMIERE":[5],"study":[6,56],"on":[7],"patients":[8,71,130,149],"with":[9,15,30,65,189],"wet":[10],"age-related":[11],"macular":[12],"degeneration":[13],"treated":[14,78],"intravitreal":[16,66,181],"ranibizumab":[17,182],"in":[18,37,47,85,98,105,126,175,209],"2006":[19],"to":[20,25,49],"2009":[21],"showed":[22],"that":[23,198],"failure":[24],"follow":[26],"recommendations":[27],"was":[28,88,158],"associated":[29],"lower":[31],"efficacy":[32],"than":[33],"had":[34],"been":[35],"observed":[36],"the":[38,45,82,106,127,178,190,193,201],"development":[39],"phase.":[40],"TWIN":[42],"Study":[43],"reviewed":[44],"situation":[46],"2010":[48],"2011.":[50],"Methods:":[51],"Retrospective,":[52],"descriptive":[53],"purely":[54],"observational":[55],"of":[57,63,129,136,180,195,205],"data":[58],"acquired":[59],"after":[60],"12":[61],"months":[62],"treatment":[64,112,138],"ranibizumab.":[67],"Results:":[68],"881":[70],"(68%":[72],"women,":[73],"mean":[74,83,107],"age,":[75],"79":[76],"years)":[77],"by":[79,186],"21":[80],"ophthalmologists,":[81],"gain":[84],"visual":[86],"acuity":[87],"+4.3":[89],"\u00b1":[90,96,117,119,162,166],"15.4":[91],"letters":[92],"(up":[93],"from":[94,115],"3.2":[95],"14.8":[97],"2006\u20132009;":[99],"NS).":[100],"Significant":[101],"improvements":[102,174],"were":[103,150],"documented":[104],"interval":[108],"between":[109],"diagnosis":[110],"and":[111,125],"initiation":[113],"(down":[114],"12.6":[116],"26.4\u20137.7":[118],"10.9":[120],"days;":[121],"P":[122,142,169],"<":[123,143,170],"0.001),":[124],"percentage":[128],"who":[131],"received":[132],"a":[133],"full":[134],"course":[135],"induction":[137],"(56.6":[139],"vs.":[140,164],"39.6%;":[141],"0.001).":[144,171],"After":[145],"induction,":[146],"hardly":[147],"any":[148],"monitored":[151],"every":[152],"month":[153],"as":[154],"recommended,":[155],"although":[156],"retreatment":[157],"more":[159],"assiduous":[160],"(5.6":[161],"2.3":[163],"5.1":[165],"2.1":[167],"injections;":[168],"Conclusion:":[172],"Despite":[173],"key":[176],"parameters,":[177],"effectiveness":[179],"is":[183,199],"still":[184],"compromised":[185],"poor":[187],"compliance":[188],"guidelines,":[191],"especially":[192],"frequency":[194],"postinduction":[196],"monitoring":[197],"now":[200],"most":[202],"important":[203],"determinant":[204],"successful":[206],"treatment.":[207],"Ranibizumab":[208],"daily":[210],"clinical":[211],"practice.":[212]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4248752180","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2022-05-12T00:00:00"}
